The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 29, 2025

Filed:

Jun. 06, 2023
Applicants:

Ruprecht-karls-universitaet Heidelberg, Heidelberg, DE;

Volker Cleeves, Weingarten, DE;

Inventors:

Volker Cleeves, Weingarten, DE;

Stephan Urban, Neustadt/Weinstrasse, DE;

Ralf Kubitz, Duesseldorf, DE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/00 (2006.01); A61K 31/00 (2006.01); A61K 31/575 (2006.01); A61K 38/16 (2006.01); A61K 38/17 (2006.01); C07K 14/005 (2006.01); C07K 14/705 (2006.01); C12N 7/00 (2006.01); G01N 33/50 (2006.01); G01N 33/68 (2006.01); G01N 33/92 (2006.01);
U.S. Cl.
CPC ...
A61K 38/162 (2013.01); A61K 31/00 (2013.01); A61K 31/575 (2013.01); A61K 38/1709 (2013.01); C07K 14/005 (2013.01); C07K 14/705 (2013.01); C12N 7/00 (2013.01); G01N 33/5023 (2013.01); G01N 33/5067 (2013.01); G01N 33/6893 (2013.01); G01N 33/92 (2013.01); C12N 2730/10122 (2013.01); C12N 2730/10132 (2013.01); G01N 2333/705 (2013.01); G01N 2500/04 (2013.01); G01N 2500/10 (2013.01); G01N 2800/085 (2013.01);
Abstract

The present invention relates to lipopeptide-based compounds for use in the diagnosis, prevention and/or treatment of a liver disease or condition, preferably liver involved metabolic diseases, as well as in the control or modification of the cholesterol level or cholesterol uptake and, thus, diagnosis, prevention and/or treatment of a cardiovascular disease. The present invention furthermore relates to an in vitro or in vivo assay or method for testing or measuring the NTCP-mediated transport of test compound(s). The present invention furthermore relates to a method for the diagnosis, prevention and/or treatment of a liver disease or condition, comprising administering a therapeutically effective amount of a lipopeptide-based compound to a patient. The present invention furthermore relates to a method for the diagnosis, prevention and/or treatment of a cardiovascular disease.


Find Patent Forward Citations

Loading…